Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (Q2170431)

From MaRDI portal
Revision as of 06:01, 1 August 2023 by Importer (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)





scientific article
Language Label Description Also known as
English
Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption
scientific article

    Statements

    Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (English)
    0 references
    0 references
    0 references
    0 references
    5 September 2022
    0 references
    causal inference
    0 references
    estimated maximum likelihood
    0 references
    principal stratification
    0 references
    principal surrogate
    0 references
    sensitivity analysis
    0 references
    vaccine efficacy curve
    0 references

    Identifiers